What is a clinical virtual twin?

A clinical virtual twin is a comprehensive virtual model of a patient built from 500+ biomarkers including genomic, metabolomic, phenotypic, behavioral, and environmental data. It enables predictive healthcare by simulating health outcomes and treatment responses with 87% accuracy.

How accurate are BioTwin's health predictions?

BioTwin achieves 87% prediction accuracy across various health conditions including cancer detection, chronic disease complications, and mental health outcomes. Our models are continuously validated through clinical studies and real-world data.

What biomarkers does BioTwin analyze?

BioTwin analyzes over 500 biomarkers across five categories: genomic markers, metabolomic profiles, phenotypic data, behavioral patterns, and environmental factors. This comprehensive approach enables holistic health assessment and prediction.

Mission

Detect cancer earlier. It's why BioTwin exists.

BioTwin exists to build a virtual twin that learns from biomarkers to detect cancer before symptoms appear. Every kit contributes to that mission. The long-term goal is early-stage detection for the cancers that today are caught too late, when treatment options are fewer and outcomes are harder to change.

Clinical pilot, active

BioTwin at Cleveland Clinic Abu Dhabi

BioTwin's first clinical pilot delivers results today to physicians at Cleveland Clinic Abu Dhabi. The pilot focuses on two specific cancers: breast cancer and colorectal cancer. Patients are referred by their physicians, not the other way around.

Results are returned to the referring physician, who interprets them in the context of the patient's full medical record. BioTwin does not deliver clinical findings directly to participants in the pilot. The programme operates entirely under the regulatory framework of the United Arab Emirates.

BioTwin works alongside Al Jalila Children's Specialty Hospital and Dubai Health on adjacent research collaborations, broadening the molecular evidence base that feeds the virtual twin.

The pilot is not a commercial service in the United States or Canada. Results are delivered through partner physicians only.

Research in progress

Beyond the pilot. BioTwin's broader research.

Beyond the UAE pilot, BioTwin runs scientific research projects across oncology, neurology, cardiology, and lifestyle conditions. These projects are not yet delivered to participants. With consent, anonymized biomarker data from BioTwin kits feeds the detection models BioTwin's research team is developing.

Research

Oncology

Lung
Pancreas
Prostate
Ovarian

+ breast & colorectal active in the UAE pilot

Research

Neurology

Alzheimer's
Parkinson's
Depression
Epilepsy

Brain biomarker signatures

Research

Cardiology

Heart failure
Hypertension

Cardiovascular risk modelling

Research

Lifestyle conditions

Diabetes
Allergies
Women's health

Metabolic & immune profiling

These are scientific research projects. Results are not yet available to participants. BioTwin's research team analyzes anonymized biomarker data from consenting participants to refine detection models.